Form 4 filings across 5 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 9 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 27 most recent Form 4 transactions.
| Apr 23 | DAWN | Day One Biopharmaceuticals… | DTOISS◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 23 | DAWN | Day One Biopharmaceuticals… | DTOISS◆ | 22,500 | — | — | — | Open the original filing on SEC.gov |
| Apr 23 | DAWN | Day One Biopharmaceuticals… | DTOISS◆ | 32,335 | — | — | — | Open the original filing on SEC.gov |
| Apr 23 | DAWN | Day One Biopharmaceuticals… | DTOISS◆ | 37,500 | — | — | — | Open the original filing on SEC.gov |
| Apr 23 | DAWN | Day One Biopharmaceuticals… | DTOISS◆ | 28,700 | — | — | — | Open the original filing on SEC.gov |
| Apr 23 | DAWN | Day One Biopharmaceuticals… | DTOISS◆ | 48,072 | — | — | — | Open the original filing on SEC.gov |
| Feb 12 | ELVN | Enliven Therapeutics, Inc. | AGRANT◆ | 1,427 | — | — | — | Open the original filing on SEC.gov |
| Jan 20 | ALXO | Alx Oncology Holdings INC | AGRANT◆ | 40,400 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | ELVN | Enliven Therapeutics, Inc. | AGRANT◆ | 59,372 | — | — | — | Open the original filing on SEC.gov |
| Nov 6, 2025 | DAWN | Day One Biopharmaceuticals… | AGRANT◆ | 32,335 | — | — | — | Open the original filing on SEC.gov |
| Nov 6, 2025 | DAWN | Day One Biopharmaceuticals… | DTOISS◆ | 32,335 | — | — | — | Open the original filing on SEC.gov |
| Nov 6, 2025 | DAWN | Day One Biopharmaceuticals… | AGRANT◆ | 37,500 | — | — | — | Open the original filing on SEC.gov |
| Nov 6, 2025 | DAWN | Day One Biopharmaceuticals… | DTOISS◆ | 37,500 | — | — | — | Open the original filing on SEC.gov |
| Nov 6, 2025 | DAWN | Day One Biopharmaceuticals… | AGRANT◆ | 28,700 | — | — | — | Open the original filing on SEC.gov |
| Nov 6, 2025 | DAWN | Day One Biopharmaceuticals… | DTOISS◆ | 28,700 | — | — | — | Open the original filing on SEC.gov |
| Nov 6, 2025 | DAWN | Day One Biopharmaceuticals… | AGRANT◆ | 48,072 | — | — | — | Open the original filing on SEC.gov |
| Nov 6, 2025 | DAWN | Day One Biopharmaceuticals… | DTOISS◆ | 48,072 | — | — | — | Open the original filing on SEC.gov |
| Sep 10, 2025 | LBRX | Lb Pharmaceuticals INC | AGRANT◆ | 22,449 | — | — | — | Open the original filing on SEC.gov |
| Sep 10, 2025 | LBRX | Lb Pharmaceuticals INC | AGRANT◆ | 3,585 | — | — | — | Open the original filing on SEC.gov |
| Sep 10, 2025 | LBRX | Lb Pharmaceuticals INC | DTOISS◆ | 3,585 | — | — | — | Open the original filing on SEC.gov |
| Sep 10, 2025 | LBRX | Lb Pharmaceuticals INC | AGRANT◆ | 17,929 | — | — | — | Open the original filing on SEC.gov |
| Sep 10, 2025 | LBRX | Lb Pharmaceuticals INC | DTOISS◆ | 17,929 | — | — | — | Open the original filing on SEC.gov |
| Jun 11, 2025 | OLMA | Olema Pharmaceuticals,… | AGRANT◆ | 24,150 | — | — | — | Open the original filing on SEC.gov |
| Jun 2, 2025 | DAWN | Day One Biopharmaceuticals… | AGRANT◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 2, 2025 | DAWN | Day One Biopharmaceuticals… | AGRANT◆ | 22,500 | — | — | — | Open the original filing on SEC.gov |